These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. Montillo M, Tedeschi A, O'Brien S, Di Raimondo F, Lerner S, Ferrajoli A, Morra E, Keating MJ. Cancer; 2003 Jan 01; 97(1):114-20. PubMed ID: 12491512 [Abstract] [Full Text] [Related]
11. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism. Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC. J Am Acad Dermatol; 2006 Sep 01; 55(3):467-77. PubMed ID: 16908353 [Abstract] [Full Text] [Related]
14. High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia. Costa D, Queralt R, Aymerich M, Carrió A, Rozman M, Vallespí T, Colomer D, Nomdedeu B, Montserrat E, Campo E. Cancer Genet Cytogenet; 2003 Nov 01; 147(1):36-43. PubMed ID: 14580769 [Abstract] [Full Text] [Related]
16. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D. Blood; 1991 Dec 15; 78(12):3269-74. PubMed ID: 1742486 [Abstract] [Full Text] [Related]
19. [Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy]. Wasser K, Moehler T, Neben K, Nosas S, Heiss J, Goldschmidt H, Hillengass J, Düber C, Kauczor HU, Delorme S. Rofo; 2004 Sep 15; 176(9):1285-95. PubMed ID: 15346264 [Abstract] [Full Text] [Related]